Free Trial

NewAmsterdam Pharma (NAMS) SEC Filings & 10K Form

NewAmsterdam Pharma logo
$25.46 -0.43 (-1.66%)
(As of 12/19/2024 05:16 PM ET)

Recent NewAmsterdam Pharma SEC Filings

DateFilerForm TypeView
12/18/2024
3:15 PM
Forbion Capital Fund IV Cooperatief U.A. (Reporting)
Forbion Growth Management B.V. (Reporting)
Forbion Growth Opportunities Fund I Cooperatief U.A. (Reporting)
Forbion IV Management B.V. (Reporting)
ForGrowth NAP B.V. (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/17/2024
4:35 PM
BCLS II Investco, LP (Filed by)
NewAmsterdam Pharma (Subject)
NewAmsterdam Pharma Co N.V. (Subject)
Form SC 13D/A
12/17/2024
4:05 PM
Bain Capital Life Sciences Fund II, L.P. (Reporting)
Bain Capital Life Sciences Fund III, L.P. (Reporting)
Bain Capital Life Sciences III General Partner, LLC (Reporting)
Bain Capital Life Sciences Investors II, LLC (Reporting)
Bain Capital Life Sciences Investors, LLC (Reporting)
BCIP Life Sciences Associates, LP (Reporting)
BCLS Fund III Investments GP, LLC (Reporting)
BCLS Fund III Investments, LP (Reporting)
BCLS II Investco , LLC (0001819101) (Reporting)
BCLS II Investco, LP (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/17/2024
3:00 PM
Forbion Capital Fund IV Cooperatief U.A. (Filed by)
NewAmsterdam Pharma (Subject)
NewAmsterdam Pharma Co N.V. (Subject)
Form SC 13D/A
12/17/2024
9:28 AM
Frazier Life Sciences X, L.P. (Filed by)
NewAmsterdam Pharma (Subject)
NewAmsterdam Pharma Co N.V. (Subject)
Form SC 13D/A
12/16/2024
3:15 PM
Forbion Capital Fund IV Cooperatief U.A. (Reporting)
Forbion Growth Management B.V. (Reporting)
Forbion Growth Opportunities Fund I Cooperatief U.A. (Reporting)
Forbion IV Management B.V. (Reporting)
ForGrowth NAP B.V. (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/13/2024
7:28 AM
NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/13/2024
5:33 AM
NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
Form 424B5
12/12/2024
3:15 PM
Forbion Capital Fund IV Cooperatief U.A. (Reporting)
Forbion Growth Management B.V. (Reporting)
Forbion Growth Opportunities Fund I Cooperatief U.A. (Reporting)
Forbion IV Management B.V. (Reporting)
ForGrowth NAP B.V. (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2024
6:57 PM
NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
Form S-3MEF
12/10/2024
3:48 PM
NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
Form 424B5
12/10/2024
6:24 AM
NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/20/2024
6:07 AM
NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/15/2024
3:29 PM
Forbion Capital Fund IV Cooperatief U.A. (Filed by)
NewAmsterdam Pharma (Subject)
NewAmsterdam Pharma Co N.V. (Subject)
Form SC 13D/A
11/14/2024
4:46 PM
NewAmsterdam Pharma (Subject)
NewAmsterdam Pharma Co N.V. (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
Form SC 13G/A
11/06/2024
7:00 AM
NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/06/2024
7:00 AM
NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/28/2024
7:02 AM
NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
Form 20-F/A
10/18/2024
3:51 PM
NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/11/2024
4:01 PM
Davidson Michael H. (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/01/2024
4:23 PM
Kooij Louise Frederika (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/01/2024
4:12 PM
Kooij Louise Frederika (Reporting)
NewAmsterdam Pharma (Subject)
NewAmsterdam Pharma Co N.V. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/30/2024
4:22 PM
Audet Juliette Berangere (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/23/2024
3:20 PM
AMGEN INC (Filed by)
NewAmsterdam Pharma (Subject)
NewAmsterdam Pharma Co N.V. (Subject)
Form SC 13G/A
08/22/2024
3:30 PM
Davidson Michael H. (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/12/2024
11:15 PM
NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
Form EFFECT
08/09/2024
4:21 PM
NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
Form 424B5
08/09/2024
4:23 PM
NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/09/2024
4:24 PM
NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
Form POS AM
08/07/2024
7:00 AM
NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/07/2024
7:00 AM
NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/29/2024
7:30 AM
NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/19/2024
3:30 PM
McKenna Mark C. (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
07/19/2024
3:30 PM
Joustra Wouter (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
07/19/2024
3:31 PM
McKenna Mark C. (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/18/2024
7:10 AM
NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/14/2024
11:15 PM
NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
Form EFFECT
07/03/2024
3:34 PM
NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
07/03/2024
3:31 PM
NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
Form S-3
Registration statement under Securities Act of 1933  
06/24/2024
7:30 AM
Davidson Michael H. (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2024
7:12 AM
NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
URGENT: This Altcoin Opportunity Won’t Wait – Act Now (Ad)

All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.

Register for the FREE Workshop Now & get $10 in Bitcoin
06/07/2024
3:15 PM
NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/09/2024
3:18 PM
NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
Form ARS
05/09/2024
7:00 AM
NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/19/2024
3:21 PM
NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
Form 424B3
04/17/2024
11:15 PM
NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
Form EFFECT
04/12/2024
3:15 PM
NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
Form POS AM
04/12/2024
3:15 PM
NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
Form POS AM
04/01/2024
7:16 AM
NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/28/2024
3:30 PM
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
Topper James N (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/27/2024
3:30 PM
Kastelein Johannes Jacob Pieter (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/26/2024
4:37 PM
Kastelein Johannes Jacob Pieter (Reporting)
NewAmsterdam Pharma (Subject)
NewAmsterdam Pharma Co N.V. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/12/2024
3:18 PM
NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
Form 424B3
03/10/2024
11:15 PM
NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
Form EFFECT
03/04/2024
7:06 AM
NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/28/2024
7:00 AM
NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/28/2024
7:11 AM
NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/21/2024
10:11 AM
Frazier Life Sciences X, L.P. (Filed by)
NewAmsterdam Pharma (Subject)
NewAmsterdam Pharma Co N.V. (Subject)
Form SC 13D/A
02/15/2024
3:15 PM
NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
Form 424B5
02/15/2024
3:18 PM
NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/25/2024
4:00 PM
LANGE LOUIS G (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
Form 3/A
01/25/2024
4:00 PM
Davidson Michael H. (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
Form 3/A
01/22/2024
7:01 AM
NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/08/2024
6:43 PM
Lewis William (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2024
6:40 PM
Lewis William (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
01/08/2024
7:21 AM
NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/04/2024
7:08 AM
NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/03/2024
4:26 PM
Kooij Louise Frederika (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2024
4:17 PM
Kastelein Johannes Jacob Pieter (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2024
4:17 PM
LANGE LOUIS G (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2024
4:19 PM
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
van der Kamp Hilde Johanna (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2024
4:21 PM
Kling Douglas F (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2024
4:10 PM
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
Somaiya Mayur Ian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2024
4:13 PM
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
Smither John W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2024
4:14 PM
Davidson Michael H. (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/29/2023
4:04 PM
Downing Nicholas (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
12/29/2023
4:09 PM
Bain Capital Life Sciences Fund II, L.P. (Reporting)
Bain Capital Life Sciences Fund III, L.P. (Reporting)
Bain Capital Life Sciences III General Partner, LLC (Reporting)
Bain Capital Life Sciences Investors II, LLC (Reporting)
Bain Capital Life Sciences Investors, LLC (Reporting)
BCIP Life Sciences Associates, LP (Reporting)
BCLS Fund III Investments GP, LLC (Reporting)
BCLS Fund III Investments, LP (Reporting)
BCLS II Investco , LLC (0001819101) (Reporting)
BCLS II Investco, LP (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
12/29/2023
3:30 PM
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
van der Kamp Hilde Johanna (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
12/29/2023
3:30 PM
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
Somaiya Mayur Ian (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
12/29/2023
3:30 PM
LANGE LOUIS G (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
12/29/2023
3:30 PM
Kooij Louise Frederika (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
12/29/2023
3:30 PM
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
Slootweg Hugo Alexander (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
12/29/2023
3:30 PM
Davidson Michael H. (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
12/29/2023
3:30 PM
Kling Douglas F (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
12/29/2023
3:30 PM
Kastelein Johannes Jacob Pieter (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
12/29/2023
3:30 PM
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
Topper James N (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
12/29/2023
3:30 PM
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
Smither John W (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
12/29/2023
3:30 PM
Audet Juliette Berangere (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
12/19/2023
11:15 PM
NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
Form EFFECT
12/19/2023
3:36 PM
NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
Form 424B3
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:NAMS) was last updated on 12/20/2024 by MarketBeat.com Staff
From Our Partners